15d-PGJ2 upregulates synthesis of IL-8 in endothelial cells through induction of oxidative stress

Antioxid Redox Signal. 2008 Dec;10(12):2035-46. doi: 10.1089/ars.2008.2032.

Abstract

15-Deoxy-Delta(12,14)-prostaglandin-J(2) (15d-PGJ(2)) is a cyclopentenone prostaglandin regarded as antiinflammatory mediator, which can act through peroxisome proliferator-activated receptor-gamma (PPARgamma) or through G protein-coupled surface receptors. It has been demonstrated that 15d-PGJ(2) potently increases the generation of interleukin-8 (IL-8) in human microvascular endothelial cells (HMEC-1s); however, the mechanism of this induction is not known. The aim of the study was to find the pathway involved in 15d-PGJ(2)-mediated IL-8 stimulation. Our data confirmed that the effect of 15d-PGJ(2) is independent of PPARgamma. For the first time, we excluded the activation of G proteins and the contribution of G protein-coupled surface receptors in endothelial cells treated with 15d-PGJ(2). Instead, we demonstrated that stimulation of IL-8 involved induction of oxidative stress, activation of p38 kinases, and increase in stability of IL-8 mRNA. Upregulation of IL-8 promoter, although measurable, seemed to play a less-pronounced role. Additionally, our results indicate the involvement of cAMP elevation and may suggest a role for ATF2 transcription factor. Concomitant induction of heme oxygenase-1 in HMEC-1s did not influence the synthesis of IL-8. In summary, we showed that 15d-PGJ(2), acting through oxidative stress, may exert proinflammatory effects. The upregulation of IL-8 is mostly associated with p38-mediated stabilization of mRNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / pharmacology
  • Cells, Cultured
  • Colforsin / pharmacology
  • Cyclic AMP / antagonists & inhibitors
  • Cyclic AMP / metabolism
  • Endothelial Cells / cytology
  • Endothelial Cells / drug effects*
  • Endothelial Cells / metabolism
  • Enzyme-Linked Immunosorbent Assay
  • Ethacrynic Acid / pharmacology
  • Ethylmaleimide / analogs & derivatives
  • Ethylmaleimide / pharmacology
  • Gene Expression / drug effects
  • Hemin / pharmacology
  • Humans
  • Hydantoins / pharmacology
  • Interleukin-8 / genetics
  • Interleukin-8 / metabolism*
  • Oxidative Stress / drug effects*
  • Prostaglandin D2 / analogs & derivatives*
  • Prostaglandin D2 / pharmacology
  • Protein Kinase Inhibitors / pharmacology
  • RNA Stability / drug effects
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Reactive Oxygen Species / metabolism
  • Receptors, Prostaglandin / agonists
  • Receptors, Prostaglandin / antagonists & inhibitors
  • Reverse Transcriptase Polymerase Chain Reaction
  • Superoxide Dismutase / genetics
  • Superoxide Dismutase / metabolism
  • Transfection
  • Xanthones / pharmacology
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • 15-deoxyprostaglandin J2
  • Hydantoins
  • Interleukin-8
  • Protein Kinase Inhibitors
  • RNA, Messenger
  • Reactive Oxygen Species
  • Receptors, Prostaglandin
  • Xanthones
  • prostanoid D receptor 1, human
  • Colforsin
  • 6-isopropoxy-9-oxoxanthene-2-carboxylic acid
  • Hemin
  • BW 245C
  • Cyclic AMP
  • Superoxide Dismutase
  • p38 Mitogen-Activated Protein Kinases
  • Ethacrynic Acid
  • Ethylmaleimide
  • Prostaglandin D2
  • Acetylcysteine